Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil Vachani

Showing results (21-30 of 210) with videos related to

Pageof 21
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Cytokine gene therapy for malignant pleural mesotheliomaAnil Vachani, Daniel H Sterman, Steven M Albelda
American Journal of Respiratory and Critical Care Medicine|April 10, 2010
Advances in diagnostic bronchoscopyAndrew R Haas, Anil Vachani, Daniel H Sterman
Medicine|March 31, 2022
Photodynamic therapy for stage I and II non-small cell lung cancer: A SEER-Medicare analysis 2000-2016Sumedha Chhatre, Septimiu Murgu, Anil Vachani, et al.
Cancers|March 6, 2021
Survival Outcomes with Photodynamic Therapy, Chemotherapy and Radiation in Patients with Stage III or Stage IV Non-Small Cell Lung CancerSumedha Chhatre, Anil Vachani, Ron R Allison, et al.
American Journal of Respiratory Cell and Molecular Biology|February 18, 2010
Gene therapy for mesothelioma and lung cancerAnil Vachani, Edmund Moon, Elliot Wakeam, et al.
Chest|September 10, 2021
The Impact of Alternative Approaches to Diagnostic Yield Calculation in Studies of BronchoscopyAnil Vachani, Fabien Maldonado, Balaji Laxmanan, et al.
Annals of Surgical Oncology|December 17, 2010
Local and systemic recurrence is the Achilles heel of cancer surgeryLouis A Aliperti, Jarrod D Predina, Anil Vachani, et al.
Lung Cancer (Amsterdam, Netherlands)|July 28, 2021
Comparative effectiveness of second-line immune checkpoint inhibitor therapy versus chemotherapy for malignant pleural mesotheliomaRoger Y Kim, Yimei Li, Melina E Marmarelis, et al.
The Clinical Journal of Pain|January 3, 2012
Natural variation in the μ-opioid gene OPRM1 predicts increased pain on third day after thoracotomyEdward Andrew Ochroch, Anil Vachani, Allan Gottschalk, et al.
The Lancet. Oncology|November 21, 2012
Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based studyRamesh Rengan, Nandita Mitra, Kaijun Liao, et al.
Pageof 21

Showing results (21-30 of 210) with videos related to

Sort By:
Pageof 21
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Cytokine gene therapy for malignant pleural mesotheliomaAnil Vachani, Daniel H Sterman, Steven M Albelda
American Journal of Respiratory and Critical Care Medicine|April 10, 2010
Advances in diagnostic bronchoscopyAndrew R Haas, Anil Vachani, Daniel H Sterman
Medicine|March 31, 2022
Photodynamic therapy for stage I and II non-small cell lung cancer: A SEER-Medicare analysis 2000-2016Sumedha Chhatre, Septimiu Murgu, Anil Vachani, et al.
Cancers|March 6, 2021
Survival Outcomes with Photodynamic Therapy, Chemotherapy and Radiation in Patients with Stage III or Stage IV Non-Small Cell Lung CancerSumedha Chhatre, Anil Vachani, Ron R Allison, et al.
American Journal of Respiratory Cell and Molecular Biology|February 18, 2010
Gene therapy for mesothelioma and lung cancerAnil Vachani, Edmund Moon, Elliot Wakeam, et al.
Chest|September 10, 2021
The Impact of Alternative Approaches to Diagnostic Yield Calculation in Studies of BronchoscopyAnil Vachani, Fabien Maldonado, Balaji Laxmanan, et al.
Annals of Surgical Oncology|December 17, 2010
Local and systemic recurrence is the Achilles heel of cancer surgeryLouis A Aliperti, Jarrod D Predina, Anil Vachani, et al.
Lung Cancer (Amsterdam, Netherlands)|July 28, 2021
Comparative effectiveness of second-line immune checkpoint inhibitor therapy versus chemotherapy for malignant pleural mesotheliomaRoger Y Kim, Yimei Li, Melina E Marmarelis, et al.
The Clinical Journal of Pain|January 3, 2012
Natural variation in the μ-opioid gene OPRM1 predicts increased pain on third day after thoracotomyEdward Andrew Ochroch, Anil Vachani, Allan Gottschalk, et al.
The Lancet. Oncology|November 21, 2012
Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based studyRamesh Rengan, Nandita Mitra, Kaijun Liao, et al.
Pageof 21